Considering that dysfunctions associated with an integrated NF-κB system appears to cause myeloma-associated inappropriate NF-κB activation, further studies ought to delineate the molecular connectivity between NF-κB pathways in diseased cells. Here, NFKB1 is linked to plasma cell myeloma.